Related Experiment Videos
Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice
1Karl-Franzens University Graz, Institute of Medical Biochemistry, Austria.
European Journal of Clinical Investigation
|June 1, 1996
Summary
Serum amyloid A (SAA) is a sensitive acute-phase protein marker for inflammation and allograft rejection. Its association with lipoproteins suggests a role in atherosclerosis development and vascular injury.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Research
Background:
- Serum amyloid A (SAA) proteins are acute-phase reactants synthesized in response to inflammatory cytokines.
- SAA levels dynamically increase during inflammatory processes, serving as objective disease activity markers.
- SAA is comparable in sensitivity to C-reactive protein (CRP) and shows promise as a marker for allograft rejection.
Purpose of the Study:
- To explore the potential role of SAA in the development of atherosclerosis.
- To investigate the association between SAA, lipoprotein abnormalities, and vascular injury.
- To evaluate SAA as a sensitive non-invasive biomarker for inflammatory conditions.
Main Methods:
- Review of clinical studies on SAA response in various disorders.
- Analysis of SAA association with plasma lipoproteins.
- Examination of SAA mRNA expression in atherosclerotic lesions.
- Investigating SAA induction by oxidized low-density lipoproteins.
Main Results:
- SAA exhibits a rapid and wide dynamic range in response to inflammation.
- SAA is a highly sensitive marker for acute-phase response and allograft rejection.
- SAA is linked to high-density lipoproteins and may play a role in atherogenesis.
- SAA mRNA is expressed in atherosclerotic lesions, and acute-phase SAA is induced by oxidized LDL.
Conclusions:
- SAA is a sensitive acute-phase reactant with potential applications in monitoring inflammatory diseases and transplant rejection.
- The association of SAA with lipoproteins and its presence in atherosclerotic lesions support its role in vascular injury and the development of atherosclerosis.